Ocular Gene Therapy
Ocular gene therapy has made a rapid progress in the past few years. This method directly administered into the eye, targeting diseases caused by mutations in the gene RPE65. Mutations in ths gene can produce Retinitis Pigmentosa, a rare but potentially Blinding diseases.
- Gene replacement
- DNA Nanoparticle
- RNA Interference
- Ex vivo for Retinal Pigmentosa
Related Conference of Ocular Gene Therapy
September 21-22, 2026
21st International Conference on Ophthalmology and Vision Science
Amsterdam, Netherlands